Since its discovery in 1975 the monoclonal antibody has become a powerful weapon in the clinical application of molecular biology. Antibodies can now be linked to novel diagnostic and therapeutic molecules in many fields of medicine, including cancer. This book examines the role of monoclonal antibodies in clinical oncology by covering new developments in the field. Its aim is to increase understanding of the applications and potential of monoclonals. The 36 chapters in this volume are written by an international group of leading experts working with monoclonal antibodies. The contributors are specialists in molecular biology, chemistry, medical physics, immunology, histopathology, nuclear medicine and clinical oncology. This book should be of interest to oncologists, radiologists, immunologists.